Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Warner, R.
Right arrow Articles by Obeid, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Warner, R.
Right arrow Articles by Obeid, A.

Chest, Vol 72, 375-379, Copyright © 1977 by American College of Chest Physicians

ARTICLES

Treatment of acute aortic insufficiency with sodium nitroferricyanide. Documentation of beneficial effect by noninvasive means

RA Warner, M Bowser, S Zuehlke, S Mookherjee and AI Obeid

The findings in a patient with acute aortic insufficiency who was treated with sodium nitroferricyanide (sodium nitroprusside) prior to aortic valve replacement are presented. Administration of the drug resulted in clinical improvement, which was reflected in changes in systemic and pulmonary arterial pressures and in noninvasive measurements. Sodium nitroferricyanide is useful in the management of patients with severe acute aortic insufficiency, and its effect may be monitored by noninvasive means.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1977 by the American College of Chest Physicians.